Clinical Trial Update: Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for CMAB009 in metastatic colorectal cancer across phase 2 and phase 3, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CMAB009

Snippet

Sponsor: Shanghai Zhangjiang Biotechnology Limited Company | Conditions: Metastatic Colorectal Cancer | Phase 2, Phase 3 | Status: COMPLETED